Company intelligence / Profile preview
Can-Fite BioPharma Ltd.
Petah Tikva/Ramat Gan, Israelcanfite.com ↗
- Ownership
- Public · CANF
- Development stage
- Phase 3
01
Overview
Can-Fite has multiple drugs in clinical development. Piclidenoson has initiated a pivotal Phase III trial for psoriasis with FDA and EMA-approved protocol. Namodenoson is enrolling patients for a pivotal Phase III study in advanced liver cancer and has received Orphan Drug Designation in the U.S. and Europe and Fast Track Designation as a second-line treatment for HCC. A Phase IIa study for pancreatic cancer is starting enrollment, and a Phase IIb study for MASH is ongoing. The company is also initiating a Phase II study for Piclidenoson in Lowe Syndrome.[1][2][6][9]
- Therapeutic areas
- GastroenterologyMen's HealthDermatologyOncologyRare Diseases
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
03
Partnerships
Cipher Pharmaceuticals (Canada)Gebro Pharma GmbH (Spain, Switzerland & Austria)Kyongbo Pharm (Korea)CMS (China, Taiwan, Hong Kong, Macao)Chong Kun Dang Pharmaceutical (Korea)Fondazione Telethon (Italy)
04
Financials
- Market cap
- $2.1M
- Total revenue
- $408.2K
- Enterprise value
- $-4.9M
Beyond the preview
Go deeper on Can-Fite BioPharma Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Can-Fite BioPharma Ltd..